First-in-human (FIH) formulation development is done for phase I-IIa CTM Manufacturing to advance FIH clinical trial and obtain proof of concept (POC) of the safety and efficacy of the molecule under ...
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your inquiry. The information you submit will be governed by our Privacy Policy.
